{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-035798","form_type":"8-K","ticker":"AORT","cik":"0000784199","company_name":"ARTIVION, INC.","filed_at":"2026-05-18T11:06:12+00:00","discovered_at":"2026-05-18T11:10:00.513873+00:00","generated_at":"2026-05-18T11:13:03.316384+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Artivion completes $135M acquisition of Endospan; adds Nexus aortic stent graft","bullets":["Net purchase price of $135M funded via $150M delayed draw term loan.","Contingent consideration up to $200M based on Nexus product performance, payable ~2 years post-close.","FDA approved Premarket Approval for Nexus branched endovascular stent graft system in April 2026.","Acquisition completes Artivion's aortic arch portfolio alongside AMDS and ARCEVO LSA devices."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-035798","json":"https://secwatch.observer/filing/0001628280-26-035798.json","markdown":"https://secwatch.observer/filing/0001628280-26-035798.md","text":"https://secwatch.observer/filing/0001628280-26-035798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/784199/000162828026035798/0001628280-26-035798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/784199/000162828026035798/aort-20260518.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T11:13:03.316384+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}